Suchergebnisse - (Standardsuche:Subject:"angiotensin II "type1" receptor blockers")

PubPharm (5)

1

The role of brain angiotensin II (type 2) receptors and nitric oxide in the renal sympathoinhibitory response to acute volume expansion in conscious rats

enthalten in: Journal of hypertension | 2017

von Abdulla, M. | Johns, E.

2

Low dose of telmisartan prevents ischemic brain damage with peroxisome proliferator-activated receptor-gamma activation in diabetic mice

enthalten in: Journal of hypertension | 2010

von Iwanami, J. | Mogi, M. | Tsukuda, K. | +5

3

Transforming growth factor beta1 and additional renoprotective effect of combination ACE inhibitor and angiotensin II receptor blocker in hypertensive subjects with minor renal abnormalities : a 24-week randomized controlled trial

enthalten in: Journal of hypertension | 2005

von Scaglione, R. | Argano, C. | Corrao, S. | +3

4

How much echo left ventricular hypertrophy would be missed in diabetics by applying the Losartan Intervention For Endpoint Reduction electrocardiogram criteria to select patients for angiotensin receptor blockade?

enthalten in: Journal of hypertension | 2004

von Dawson, A. | Rana, B. | Pringle, S. | +3

5

Pharmacokinetic-pharmacodynamic interactions of candesartan cilexetil and losartan

enthalten in: Journal of hypertension | 1999

von Azizi, M. | Chatellier, G. | Guyene, T. | +1

1
[1]